Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data - Concepedia

Concepedia

Publication | Closed Access

Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data

10

Citations

17

References

2011

Year

Philip J. Mease, Peter Zimetbaum, Mei Sheng Duh, Francis Vekeman, Annie Guérin, Mariette Boerstoel-Streefland, Wenjun Jiang, Patrick Lefèbvre

Annals of Pharmacotherapy

Abstract

This French population-based study found that the risk of CV events was not significantly different for patients receiving milnacipran versus those receiving venlafaxine or amitriptyline.

References

	Year	Citations

Page 1